Brown Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$553K Sell
461
-1,505
-77% -$1.54M 0.12% 79
2026
Q1
$1.81M Buy
1,966
+30
+2% +$30.4K 0.46% 37
2025
Q4
$2.08M Buy
1,936
+140
+8% +$134K 0.55% 34
2025
Q3
$1.37M Sell
1,796
-33
-2% -$24.6K 0.38% 45
2025
Q2
$1.43M Buy
1,829
+112
+7% +$87K 0.44% 44
2025
Q1
$1.42M Buy
1,717
+38
+2% +$31.6K 0.49% 42
2024
Q4
$1.3M Sell
1,679
-5
-0.3% -$4.14K 0.46% 37
2024
Q3
$1.49M Buy
1,684
+68
+4% +$61.1K 0.54% 34
2024
Q2
$1.46M Buy
1,616
+1
+0.1% +$800 0.59% 33
2024
Q1
$1.26M Buy
1,615
+6
+0.4% +$4.27K 0.52% 34
2023
Q4
$938K Hold
1,609
0.42% 40
2023
Q3
$864K Sell
1,609
-43
-3% -$22.2K 0.41% 39
2023
Q2
$775K Buy
+1,652
New +$693K 0.4% 42

Other funds holding LLY

Brown Wealth Management's LLY Position: Q2 2026 in Review

Brown Wealth Management reduced its Eli Lilly (LLY) stake by 77% in Q2 2026, selling an estimated $1.54M and leaving 461 shares worth $553K. The position accounts for 0.12% of the portfolio, ranked #79.

Brown Wealth Management first reported a position in LLY in Q2 2023 and has held it in 13 quarters since. The position peaked at $2.08M in Q4 2025. 1,086 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Brown Wealth Management held 461 shares of Eli Lilly worth $553K as of Q2 2026.
  • Brown Wealth Management sold 1,505 Eli Lilly shares in Q2 2026, an estimated $1.54M.
  • Eli Lilly made up 0.12% of Brown Wealth Management's portfolio in Q2 2026, its #79 holding.
  • Brown Wealth Management first reported a position in Eli Lilly in Q2 2023 and has held it in 13 quarters since.
  • Brown Wealth Management's Eli Lilly position peaked at $2.08M in Q4 2025.
  • 1,086 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Brown Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.